1-4 of 4
Naoto Hirano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A047: Tumor specific γδ T cells expand and respond to PD-1 blockade

Scott C. Lien, Dalam Ly, S.Y. Cindy Yang, Ben X. Wang, Michael St. Paul, Ramy Gadalla, Babak Noamani, Sarah Boross-Harmer, Trevor J. Pugh, Anna Spreafico, Naoto Hirano, Albiruni R.A. Razak, Pamela S. Ohashi
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (12_Supplement): A047.
https://doi.org/10.1158/2326-6074.TUMIMM23-A047
Published: 01 December 2023
View article titled, Abstract A047: Tumor specific γδ T cells expand and respond to PD-1 blockade
Journal Articles

Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy

Yuki Kagoya, Tingxi Guo, Brian Yeung, Kayoko Saso, Mark Anczurowski, Chung-Hsi Wang, Kenji Murata, Kenji Sugata, Hiroshi Saijo, Yukiko Matsunaga, Yota Ohashi, Marcus O. Butler, Naoto Hirano
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (7): 926–936.
https://doi.org/10.1158/2326-6066.CIR-18-0508
Published: 01 July 2020
View article titled, Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy
Open the PDF for Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract PR09: A novel chimeric antigen receptor containing JAK-STAT signaling domains mediates superior antitumor effects

Yuki Kagoya, Shinya Tanaka, Marcus O. Butler, Mark Minden, Naoto Hirano
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (3_Supplement): PR09.
https://doi.org/10.1158/2326-6074.TUMIMM16-PR09
Published: 28 February 2017
View article titled, Abstract PR09: A novel chimeric antigen receptor containing JAK-STAT signaling domains mediates superior antitumor effects
Journal Articles

Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy

Toshiki Ochi, Munehide Nakatsugawa, Kenji Chamoto, Shinya Tanaka, Yuki Yamashita, Tingxi Guo, Hiroshi Fujiwara, Masaki Yasukawa, Marcus O. Butler, Naoto Hirano
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (9): 1070–1081.
https://doi.org/10.1158/2326-6066.CIR-14-0222
Published: 03 September 2015
View article titled, Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy
Open the PDF for Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy in another window
Includes: Supplementary data